A/Prof Jim Jackson

Radiation Oncologist
Refer a patient

A/Prof Jim Jackson is an experienced, supportive radiation oncologist who is committed to delivering prompt, personalised cancer treatment for those in his care. He is passionate about cutting-edge radiation therapy and maintains an active involvement in clinical research to deliver the best possible outcomes for his patients.


A/Prof Jim Jackson is a radiation oncologist at Icon Cancer Centre Gold Coast. He completed his medical degree (MBBS) at the University of Queensland in 2004. Prior to this A/Prof Jackson had completed a Bachelor of Arts in Psychology at the University of California, Los Angeles (UCLA) and is currently a PhD candidate at Monash University, where he is investigating methods to reduce side effects of cancer treatment.

A/Prof Jackson completed his radiation oncology training in Queensland and in 2012, he undertook a clinical research fellowship at the Austin-Olivia Newton-John Cancer and Wellness Centre in Image Guided and Intensity Modulated Radiation Therapy (IMRT). In January 2014, he joined Icon Cancer Centre Gold Coast bringing his expertise in providing state-of-the-art treatment techniques including stereotactic radiation therapy for lung and brain tumours.

A/Prof Jackson has special interests in brain, head and neck, gynaecological, genitourinary, lung, skin and breast cancers. He enjoys teaching medical students and is a research supervisor for radiation oncology trainees and university students.  He holds appointments as Honorary Adjunct Assistant Professor at Bond University and Senior Lecturer in Medicine at Griffith University.

He is a member of the Icon Cancer Centre Research Committee and has held several roles with the Royal Australia and New Zealand College of Radiologists (RANZCR), at a national level.  In October 2016, he served as scientific co-convenor for the RANZCR Annual Scientific Meeting, at the Gold Coast Exhibition and Convention Centre.  He is a member of both the American and European Radiation Oncology Societies and regularly reviews scientific papers for national and international medical journals.

Affiliations & Memberships

  • Honorary Adjunct Assistant Professor at Bond University
  • Senior Lecturer in Medicine at Griffith University
  • Royal Australia and New Zealand College of Radiologists (RANZCR)
  • American Radiation Oncology Society
  • European Radiation Oncology Society
  • Australia and New Zealand Urogenital and Prostate Cancer Trials Group
  • Australia and New Zealand Head and Neck Cancer Society

Special Interests

A/Prof Jim Jackson accepts referrals for all cancer types, with special clinical interests in:
  • Brain cancer
  • Breast cancer
  • Genitourinary cancer
  • Head and neck cancer
  • Lung cancer

Icon Locations

Gold Coast Private Hospital View centre
Gold Coast University Hospital View centre
North Lakes View centre
Greenslopes View centre


  • Anderson NJ, Jackson JE Smith JG, Wada M, Schneider M, Poulsen M, Rolfo M, Fahandej M Gan H, Joon DL, Khoo V Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer. Head Neck. 2018 May 13. doi: 10.1002/hed.25316. [Epub ahead of print]

  • 2017 Jackson JE (Co-Author) Chapter 44 Aggressive Non-melanoma Skin Cancer. In Bell RB, Andersen PA, Fernandes R. Oral, Head and Neck Oncology and Reconstructive Surgery. (1st Edition). Cambridge, MA: Elsevier Inc.

  • Lehman, Margot, Gorayski, Peter, Watson, Susanne, Edeling, Desiree, Jackson, James and Whitty, Jennifer (2016) Patient preferences regarding prophylactic cranial irradiation: a discrete choice experiment. Radiotherapy and Oncology, 121 2: 225-231. doi:10.1016/j.radonc.2016.09.003

  • Jackson JE, Burmeister BH, Burmeister E, Foote MC, Thomas JM, Smithers BM. Melanoma Brain Metastases: The Impact of Nodal Disease. Clin Exp Metastasis. 2014 Jan;31(1):81-5. doi:10.1007/s10585-013-9611-8. Epub 2013 Aug 23.


  • Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA.  Multidisciplinary Clinic Care Improves Adherence to Best Practice in Head and Neck Cancer.  Am J Otolaryngol. 2013 Jan; 34(1): 57-60. https://www.ncbi.nlm.nih.gov/pubmed/23218113

  • Lin C, Tripcony L, Keller J, Poulsen M, Martin J, Jackson J, Dickie G. Perineural Infiltration of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma Without Clinical FeaturesInt J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):334-40.

  • Jackson JE, Dickie GJ, Wiltshire KL, Keller J, Tripcony L, Poulsen MG, Hughes M, Allison RW, Martin JM. Radiotherapy for Perineural Invasion in Cutaneous Head and Neck Carcinomas: Towards a Risk Adaptive Treatment Approach. Head and Neck. 2009 May; 31 (5) 604-610. https://www.ncbi.nlm.nih.gov/pubmed/19132719


  • Jackson JE, Dickie GJ, Poulsen MG, Martin JM. Author Reply Existence of MRI-negative clinical (large nerve) perineural squamous cell carcinoma spread. Head and Neck 2009 Nov; 31(11):1532-3. https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.20991


View all Doctors